What is NDC 80777-500?

80777-500 is the product NDC for mFLUSIVA, RNA-101-bfl3 12.5 ug/.38mL + 2 more ingredients injection, suspension, listed with the FDA by Moderna US, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

mFLUSIVA (Influenza Vaccine, mRNA).

What is the active ingredient?

RNA-101-bfl3, RNA-101-bfl6, RNA-101-bfl5.

Moderna US, Inc., NDC labeler code 80777. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for mFLUSIVA?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

mFLUSIVA NDC 80777-500 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)80777-500Labeler and product segments. Claims need a package NDC.

Product NDC at billing width80777-0500Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
80777-500-20	80777050020	10 SYRINGE, PLASTIC in 1 CARTON (80777-500-20) / .38 mL in 1 SYRINGE, PLASTIC (80777-500-18)Marketed from Aug 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): mFLUSIVA
Generic name (nonproprietary): influenza vaccine, mrna
Active ingredients: RNA-101-bfl3 — 12.5 ug/.38mLRNA-101-bfl6 — 12.5 ug/.38mLRNA-101-bfl5 — 12.5 ug/.38mL
Dosage form: Injection, Suspension
Route: Intramuscular
Labeler: Moderna US, Inc.NDC labeler code 80777
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125869
Marketing start: Aug 5, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 80777-500_3dd1c6d2-b054-4803-bb21-460b1b090d4cSPL ID 3dd1c6d2-b054-4803-bb21-460b1b090d4c

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N480777050020 followed by a unit qualifier and the quantity

Package 80777-0500-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 80777-500

What is NDC 80777-500?: 80777-500 is the product NDC for mFLUSIVA, RNA-101-bfl3 12.5 ug/.38mL + 2 more ingredients injection, suspension, listed with the FDA by Moderna US, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: mFLUSIVA (Influenza Vaccine, mRNA).
What is the active ingredient?: RNA-101-bfl3, RNA-101-bfl6, RNA-101-bfl5.
Who is the labeler?: Moderna US, Inc., NDC labeler code 80777. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for mFLUSIVA?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

mFLUSIVA (Influenza vaccine, mrna) NDC 80777-500